Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Glioblastoma 8Neoplasms 4Brain Neoplasms 4Endometrial Neoplasms 3Breast Neoplasms 3Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Non-alcoholic Fatty Liver Disease 1Multiple Myeloma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Kidney Neoplasms 1Ketogen-based Therapeutic Diet 1Intermittent Fasting 1Head and Neck Neoplasms 1Growth Hormone-Secreting Pituitary Adenoma 1Glioma 1Fatty Liver 1Estrogen Receptor-positive Breast Cancer 1Drug Resistant Epilepsy 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Autism Spectrum Disorder 1Adenocarcinoma of Lung 1

Interventions

Sunitinib 145Nivolumab 144pembrolizumab 132Sorafenib 84Bevacizumab 77Everolimus 74cabozantinib 71pazopanib 65Axitinib 65Ipilimumab 62aldesleukin 52Magnetic Resonance Spectroscopy 45Cyclophosphamide 40Interleukin-2 38lenvatinib 37Specimen Handling 36Radiosurgery 36Interferon-alpha 32atezolizumab 30temsirolimus 27belzutifan 24Gemcitabine 23fludarabine phosphate 22avelumab 22Radiotherapy 19Interferon alpha-2 19Biopsy 18fludarabine 17durvalumab 17Nephrectomy 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Diet, Ketogenic × Clear all
NCT06896552 2025-03-26

Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.

Rabin Medical Center

Phase 1/2 Not yet recruiting
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡